Single fixed low-dose rituximab as induction therapy suppresses de novo donor-specific anti-HLA antibody production in ABO compatible living kidney transplant recipients

Antibody-Mediated Rejection of Solid-Organ Allografts

(2018) Alexandre Loupy et al.   NEW ENGLAND JOURNAL OF MEDICINE

Role of de novo donor-specific anti-HLA antibodies in kidney graft failure: A case-control study

(2017) A. Castro et al.   HLA

The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology

(2016) A. Loupy et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Outcomes of Kidney Transplantation from Circulatory Death Donors With Increased Terminal Creatinine Levels in Serum

(2016) Yusuke Tomita et al.   TRANSPLANTATION

De Novo Anti-HLA DSA Characteristics and Subclinical Antibody-Mediated Kidney Allograft Injury

(2016) Takayuki Yamamoto et al.   TRANSPLANTATION

Rituximab as Induction Therapy After Renal Transplantation: A Randomized, Double-Blind, Placebo-Controlled Study of Efficacy and Safety

(2015) M. W. F. van den Hoogen et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Rates and Determinants of Progression to Graft Failure in Kidney Allograft Recipients WithDe NovoDonor-Specific Antibody

(2015) C. Wiebe et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Longitudinal Analysis of T and B Cell Phenotype and Function in Renal Transplant Recipients with or without Rituximab Induction Therapy

(2014) Elena G. Kamburova et al.   PLoS One

Anti-B cell therapy with rituximab as induction therapy in renal transplantation

(2014) I. Joosten et al.   TRANSPLANT IMMUNOLOGY

De Novo Donor-Specific Human Leukocyte Antigen Antibodies Early After Kidney Transplantation

(2014) Raymond L. Heilman et al.   TRANSPLANTATION

Prolonged, Low-Dose Anti-Thymocyte Globulin, Combined with CTLA4-Ig, Promotes Engraftment in a Stringent Transplant Model

(2013) Francesca D’Addio et al.   PLoS One

Rituximab-induced direct inhibition of T-cell activation

(2012) Dina Stroopinsky et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

A Randomized, Double-Blind, Placebo-Controlled Study of Single Dose Rituximab as Induction in Renal Transplantation

(2012) Gunnar Tydén et al.   TRANSPLANTATION

Evaluation of Alloreactivity in Kidney Transplant Recipients Treated with Antithymocyte Globulin Versus IL-2 Receptor Blocker

(2011) L. Cherkassky et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Chronic Antibody-Mediated Rejection Is Reduced by Targeting B-Cell Immunity During an Introductory Period

(2011) N. Kohei et al.   AMERICAN JOURNAL OF TRANSPLANTATION

B1a B Lymphocytes Are Atheroprotective by Secreting Natural IgM That Increases IgM Deposits and Reduces Necrotic Cores in Atherosclerotic Lesions

(2011) Tin Kyaw et al.   CIRCULATION RESEARCH

Inotuzumab Ozogamicin Murine Analog-Mediated B-Cell Depletion Reduces Anti-islet Allo- and Autoimmune Responses

(2011) M. Carvello et al.   DIABETES

The 5-Year Outcome of ABO-Incompatible Kidney Transplantation With Rituximab Induction

(2011) Shohei Fuchinoue et al.   TRANSPLANTATION

Preexisting Donor-Specific HLA Antibodies Predict Outcome in Kidney Transplantation

(2010) C. Lefaucheur et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Evaluation of Low-Dose Rituximab Induction Therapy in Living Related Kidney Transplantation

(2010) Toshio Takagi et al.   TRANSPLANTATION

Incidence and Predictive Factors for Infectious Disease after Rituximab Therapy in Kidney-Transplant Patients

(2009) N. Kamar et al.   AMERICAN JOURNAL OF TRANSPLANTATION

A Randomized, Doubleblind, Placebo-Controlled, Study of Single-Dose Rituximab as Induction in Renal Transplantation

(2009) Gunnar Tydén et al.   TRANSPLANTATION